R
Raghavan Murugan
Researcher at National Institute of Technology, Silchar
Publications - 138
Citations - 5889
Raghavan Murugan is an academic researcher from National Institute of Technology, Silchar. The author has contributed to research in topics: Acute kidney injury & Renal replacement therapy. The author has an hindex of 33, co-authored 126 publications receiving 3838 citations. Previous affiliations of Raghavan Murugan include Anna University & Annamalai University.
Papers
More filters
Journal ArticleDOI
Reactive Oxygen Species-Induced Lipid Peroxidation in Apoptosis, Autophagy, and Ferroptosis.
Lianjiu Su,Jiahao Zhang,Hernando Gomez,Raghavan Murugan,Xing Hong,Dongxue Xu,Fan Jiang,Zhiyong Peng,Zhiyong Peng +8 more
TL;DR: This review discussed how ROS propagate lipid peroxidation chain reactions and how the products of lipidperoxidation initiate apoptosis and autophagy in current models, and summarized lipid per oxidation in pathological conditions of critical illness.
Journal ArticleDOI
Angiotensin II for the Treatment of Vasodilatory Shock.
Ashish Khanna,Shane W. English,Xueyuan S. Wang,Kealy R. Ham,James A. Tumlin,Harold M. Szerlip,Laurence W. Busse,Laith Altaweel,Timothy E Albertson,Caleb Mackey,Michael T. McCurdy,David W. Boldt,Stefan N. Chock,Paul J Young,Kenneth Krell,Richard G. Wunderink,Marlies Ostermann,Raghavan Murugan,Michelle N. Gong,Rakshit Panwar,Johanna Hästbacka,Raphael Favory,Balasubramanian Venkatesh,B. Taylor Thompson,Rinaldo Bellomo,Jeffrey B. Jensen,Jeffrey B. Jensen,Stew Kroll,Lakhmir S. Chawla,George F. Tidmarsh,George F. Tidmarsh,George F. Tidmarsh,Adam M. Deane +32 more
TL;DR: Angiotensin II effectively increased blood pressure in patients with vasodilatory shock that did not respond to high doses of conventional vasopressors.
Journal ArticleDOI
Classifying AKI by Urine Output versus Serum Creatinine Level
John A. Kellum,Florentina E. Sileanu,Raghavan Murugan,Nicole Lucko,Andrew D. Shaw,Gilles Clermont +5 more
TL;DR: It is concluded that short- and long-term risk of death or RRT is greatest when patients meet both the serum creatinine level and urine output criteria for AKI and when these abnormalities persist.
Journal ArticleDOI
Acute kidney injury: what's the prognosis?
Raghavan Murugan,John A. Kellum +1 more
TL;DR: Emerging evidence suggests that survivors of AKI incur long-term risks for developing chronic kidney disease and end-stage renal disease compared with those without AKI, and further work is required to better understand the pathogenesis ofAKI during critical illness and to develop novel treatments.
Journal ArticleDOI
Acute kidney injury in non-severe pneumonia is associated with an increased immune response and lower survival
Raghavan Murugan,Vijay Karajala-Subramanyam,MinJae Lee,Sachin Yende,Lan Kong,Melinda Carter,Derek C. Angus,John A. Kellum +7 more
TL;DR: In general, patients with acute kidney injury were older, had more comorbidity, and had higher biomarker concentrations (interleukin-6, tumor necrosis factor, D-dimer) even among patients without severe sepsis, which indicates acute kidneys injury is common evenamong patients with non-severe pneumonia and is associated with higher immune response and an increased risk of death.